![Stanley Frankel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Stanley Frankel
Director/Board Member at
PRECISION BIOSCIENCES, INC.
Net worth: 259 652 $ as of 29/09/2026
Profile
Stanley R.
Frankel is an Independent Non-Executive Director at Precision BioSciences, Inc. since 2021.
Dr. Frankel is an Independent Director at CREATE Medicines, Inc. (Massachusetts) since 2022.
Formerly, Dr. Frankel was SVP-Global Drug Development & Cellular Therapy at Bristol Myers Squibb Co. from 2019 to 2020.
Dr. Frankel was VP, Head-Clinical Research & Development at Celgene Corp.
from 2015 to 2019.
Dr. Frankel was Chief Medical Officer at Cytovia Therapeutics, Inc. Education includes a doctorate from Northwestern University and an undergraduate degree from Harvard College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 27/09/2026 | 41,478 ( 0.17% ) | 259 652 $ | 29/09/2026 |
Stanley Frankel active positions
| Companies | Position | Start |
|---|---|---|
| PRECISION BIOSCIENCES, INC. | Director/Board Member | 11/04/2021 |
Myeloid Therapeutics, Inc.
 Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Director/Board Member | 29/06/2022 |
Former positions of Stanley Frankel
| Companies | Position | End |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 30/09/2020 |
| CELGENE | Chief Tech/Sci/R&D Officer | 31/10/2019 |
Cytovia Therapeutics, Inc.
 Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Chief Tech/Sci/R&D Officer | - |
Education of Stanley Frankel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
72
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Develops cancer and immunology drugs | Health Technology |
Precision BioSciences, Inc.
 Precision BioSciences, Inc. BiotechnologyHealth Technology Develops technology to produce custom, genome-editing enzymes for human health and biological research | Health Technology |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard College
 Harvard College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Myeloid Therapeutics, Inc.
Myeloid Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutic drugs for the treatment of tumors and autoimmune diseases | Health Technology |
Cytovia Therapeutics, Inc.
Cytovia Therapeutics, Inc. BiotechnologyHealth Technology Develops immunotherapies for cancer and infectious diseases | Health Technology |
- Stock Market
- Insiders
- Stanley Frankel
